Bortezomib D-mannitol Unknown Status Phase 4 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02559154Modified Bortezomib-based Combination Therapy for Multiple Myeloma